Untapped Potential of Social Media Listening in Medical Affairs with Damian Eade
38m
·
Medical Affairs Unscripted
·
Social media listening is an area with great untapped potential in the pharmaceutical industry. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Damian Eade, Managing Director, Social Analytics, Insight at Lumanity, discuss how a Medical Affairs team approaches social media listening differently than a commercial team. They review the differences between traditional key opinion leaders and digital thought leaders as well as discuss the impact these “digital influencers” have in the social media landscape. They talk through insight collection and learning about the patient experience through social media and how these insights can be leveraged for patient-focused drug development. Finally, Damian and Peg explore sentiment analysis and how it can be measured and used in social media. With all of the advancements being made in the digital landscape, staying at the forefront of social media listening can be a powerful tool for Medical Affairs teams.
The episode Untapped Potential of Social Media Listening in Medical Affairs with Damian Eade from the podcast Medical Affairs Unscripted has a duration of
38:21. It was first published
More episodes from Medical Affairs Unscripted
The Value of Medical Affairs – Strategic Thinking and Continuity from Clinical Development to Commercialization and Beyond With Jodi Smith, PhD
In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Jodi Smith, PhD, the Global Medical Strategy Lead in Thoracic Oncology at Pfizer, discuss the value of Medical Affairs. While they agree that there’s a cost associated with bringing Medical Affairs into the early development of a drug, they see a clear and measurable benefit, from accelerated enrollment to having a solid foundation for commercialization.Through their many years in different roles within Medical Affairs, they know that to achieve these benefits, organizations need to have the right team members in the right roles with the agility to work in an ever-changing landscape as well as provide strategic thinking, a diversity of audience, and continuitythroughout the product lifecycle - from clinical development through commercialization and beyond.
Excellence in Leadership – International Women’s Day Special With Aree Cheshire, PhD, and Amber Gilbert, MBA
Curiosity, empathy, authenticity, strength.Good leaders express many key characteristics and come in all shapes and sizes. In this special International Women’s Day episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity,Aree Cheshire, PhD, VP of Client Strategy in UK Communications at Lumanity, and Amber Gilbert, MBA, Global Practice Lead for Value, Access & Outcomes at Lumanity, meet todiscuss excellence in leadership.During their conversation they touch on whether good leadership qualities are innate or learned, how to balance being a leader versus a “do-er”, and how to approach leadership differently during challenging times.Other areas of focus include how strategic thinking plays into leadership, and what types of skills or knowledge are required to succeed as a leader. Finally, they discusshowwomen in leadership roles todaycanhelp pave the way for the next generation of strong female leaders.
The Patient Impact in Drug Development and Value Demonstration with Len Lichtenfeld, MD, MACP
Now, more than ever, the patient voice is being heard by the pharmaceutical industry. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Len Lichtenfeld, MD, MACP meet to discuss the ways patients are providing advisement in drug development and valuation. After hearing about Len’s extensive experience, they delve into the new regulatory changes coming to pharma and biotech that will require the patient experience to be taken into consideration during the drug development process. They conclude by discussing how the patient experience is having an impact on the valuation of new drugs.
The Role of the MSL in Clinical Trial Enrollment with Dan Hennessy PhD
Having a clinical trial that is properly supported and engaged is no easy feat, but accomplishing this can greatly improve the success of your asset. In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Dan Hennessy PhD,Vice President of Medical Affairs at Merus N.V.,meet for a second time to discuss MSL and stakeholder engagement. They delve more specifically into the key role that Medical Affairs plays in accelerating and improving clinical trial enrollment and highlight how to use MSLs and a Field Medical team in different ways to ensure that you get the most value from the team, both from a US and a Global perspective. As they conclude, they explore what kinds of skills are required of a well-prepared Field Medical team and how to ensure they are properly prepared.
Podcast Bytes - The Digital Transformation of Medical Affairs with Christian Dimaano, PhD, MPH
Medical Affairs is going through a digital transformation. What this means, what it will look like, and what value it will bring to pharmaceutical and biotech companies is still unknown. In this third episode of our short form podcast series, we discuss this topic with Christian Dimaano, PhD, MPH. As the VP, Head of Medical Affairs at Kinnate Biopharma, he has a wealth of Medical Affairs experience and insights. This conversation brings us furtheralong in trying tounderstand the changes that are coming to the industry.